Thrombocytopenia Induced by Imatinib Mesylate (Glivec) in Patients with Chronic Myelogenous Leukemia: is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?

✍ Scribed by Keisuke Miyazawa; Jiroh Nishimaki; Tomoko Katagiri; Goro Sashida; Nahoko Shoji; Ken Kawakubo; Akitaka Suzuki; Takashi Shimamoto; Akihiko Gotoh; Yuzuru Kuriyama; Yoshikazu Ito; Tetsuzo Tauchi; Yoshikazu Kawanishi; Yukihiko Kimura; Kazuma Ohyashiki

• Book ID: 105675545
• Publisher: Carden Jennings Publishing
• Year: 2003
• Tongue: English
• Weight: 113 KB
• Volume: 77
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/bf02982610